| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.19B | — | +15.0% |
| Cost of Revenue | $441.6M | — | -1.2% |
| Gross Profit | $750.3M | — | +27.4% |
| R&D Expense | $145.3M | — | +0.1% |
| SG&A Expense | $349.7M | — | +12.8% |
| Operating Income | $255.3M | — | +90.9% |
| Interest Expense | $2.1M | — | -43.2% |
| Pre-tax Income | $269.5M | — | +74.7% |
| Income Tax | $70.0M | — | +43.1% |
| Net Income | $199.5M | — | +89.3% |
| EPS (Basic) | $0.52 | — | +92.6% |
| EPS (Diluted) | $0.51 | — | +88.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.12B | +21.8% | +23.6% |
| Accounts Receivable | $1.09B | -10.5% | -5.8% |
| Inventory | $693.6M | +10.3% | +28.9% |
| Current Assets | $4.33B | +7.4% | -4.9% |
| Total Assets | $6.63B | +4.6% | -1.8% |
| Current Liabilities | $2.22B | +3.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $525.6M | — | +186.0% |
| Capital Expenditures | $76.6M | — | -12.0% |
| Investing Cash Flow | -$298.5M | — | -397.9% |
| Financing Cash Flow | -$25.0M | — | -300.0% |
| Free Cash Flow | $449.0M | — | +363.8% |
| -26.8% |
| Total Liabilities | $3.68B | +2.3% | -18.0% |
| Stockholders' Equity | $2.96B | +7.7% | +30.5% |